Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, March 10, 2022
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
[ Thu, Mar 10th 2022
] - WOPRAI
Joseph Catanzaro Maintained (SNSE) at Buy with Decreased Target to $10 on, Mar 10th, 2022
Joseph Catanzaro of Piper Sandler, Maintained "Sensei Biotherapeutics, Inc." (SNSE) at Buy with Decreased Target from $12 to $10 on, Mar 10th, 2022.
Joseph, nor any peers, have made any analyst calls on SNSE in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30